Free Trial
NASDAQ:DERM

Journey Medical (DERM) Stock Price, News & Analysis

Journey Medical logo
$7.15 -0.12 (-1.65%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Journey Medical Stock (NASDAQ:DERM)

Key Stats

Today's Range
$7.07
$7.51
50-Day Range
$6.38
$8.54
52-Week Range
$3.54
$8.90
Volume
57,477 shs
Average Volume
110,240 shs
Market Capitalization
$174.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.17
Consensus Rating
Moderate Buy

Company Overview

Journey Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

DERM MarketRank™: 

Journey Medical scored higher than 35% of companies evaluated by MarketBeat, and ranked 767th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Journey Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Journey Medical has only been the subject of 3 research reports in the past 90 days.

  • Read more about Journey Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Journey Medical are expected to grow in the coming year, from ($1.02) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Journey Medical is -18.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Journey Medical is -18.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Journey Medical has a P/B Ratio of 9.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Journey Medical's valuation and earnings.
  • Percentage of Shares Shorted

    13.91% of the float of Journey Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Journey Medical has a short interest ratio ("days to cover") of 8.9.
  • Change versus previous month

    Short interest in Journey Medical has recently increased by 9.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Journey Medical does not currently pay a dividend.

  • Dividend Growth

    Journey Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.91% of the float of Journey Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Journey Medical has a short interest ratio ("days to cover") of 8.9.
  • Change versus previous month

    Short interest in Journey Medical has recently increased by 9.01%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Journey Medical has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Journey Medical this week, compared to 3 articles on an average week.
  • Search Interest

    7 people have searched for DERM on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Journey Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.03% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.25% of the stock of Journey Medical is held by institutions.

  • Read more about Journey Medical's insider trading history.
Receive DERM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DERM Stock News Headlines

Journey Medical Corp Enters New Sales Agreement
Journey Medical (NASDAQ:DERM) Now Covered by HC Wainwright
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Q3 Earnings Estimate for Journey Medical Issued By B. Riley
See More Headlines

DERM Stock Analysis - Frequently Asked Questions

Journey Medical's stock was trading at $3.91 on January 1st, 2025. Since then, DERM stock has increased by 82.9% and is now trading at $7.15.

Journey Medical Corporation (NASDAQ:DERM) posted its quarterly earnings data on Tuesday, August, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.09. The business had revenue of $15.01 million for the quarter, compared to the consensus estimate of $14.93 million. Journey Medical had a negative net margin of 15.49% and a negative trailing twelve-month return on equity of 48.69%.
Read the conference call transcript
.

Journey Medical (DERM) raised $39 million in an initial public offering on Friday, November 12th 2021. The company issued 3,520,000 shares at $10.00-$12.00 per share.

Top institutional investors of Journey Medical include Wasatch Advisors LP (4.94%), Geode Capital Management LLC (1.13%), Opaleye Management Inc. (0.41%) and Envestnet Asset Management Inc. (0.30%). Insiders that own company stock include Claude Maraoui, Ramsey Alloush, Lindsay A Md Rosenwald, Justin Adam Smith and Joseph Benesch.
View institutional ownership trends
.

Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Journey Medical investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Adobe (ADBE) and AppLovin (APP).

Company Calendar

Last Earnings
8/12/2025
Today
8/29/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DERM
Previous Symbol
NASDAQ:DERM
CIK
1867066
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$10.50
Potential Upside/Downside
+70.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.67 million
Net Margins
-15.49%
Pretax Margin
-15.28%
Return on Equity
-48.69%
Return on Assets
-11.26%

Debt

Debt-to-Equity Ratio
1.11
Current Ratio
1.27
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$56.13 million
Price / Sales
3.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.79 per share
Price / Book
9.05

Miscellaneous

Outstanding Shares
24,380,000
Free Float
20,714,000
Market Cap
$174.32 million
Optionable
N/A
Beta
0.80

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:DERM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners